Kamila Kássia dos Santos Oliveira

Kamila Kássia dos Santos Oliveira

Auto-generated profile, based on publicly available information

Kamila Kássia dos Santos Oliveira

Institute Aggeu Magalhães, Laboratory of Immunoparasitology Oswaldo Cruz Foundation‐FIOCRUZ Recife Pernambuco Brazil

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 April 2023 in Parasite Immunology
Verified
Journal Article
Closed access
LMLeyllane Rafael Moreira
Leyllane Rafael Moreira
KOKamila Kássia dos Santos Oliveira
Kamila Kássia dos Santos Oliveira
DTDiego José Lira Torres
Diego José Lira Torres
MBMichelle da Silva Barros
Michelle da Silva Barros
TATiago Ribeiro de Arruda
Tiago Ribeiro de Arruda
VLVirginia Maria Barros de Lorena
Virginia Maria Barros de Lorena

20 January 2023 in Natural Product Research
Verified
Journal Article
Closed access
JJJosé Noé da Silva Júnior
José Noé da Silva Júnior
ASAna Carla da Silva
Ana Carla da Silva
KOKamila Kássia dos Santos Oliveira
Kamila Kássia dos Santos Oliveira
LMLeyllane Rafael Moreira
Leyllane Rafael Moreira
SSSilvana Ferreira da Silva
Silvana Ferreira da Silva
APAna Lucia Figueiredo Porto
Ana Lucia Figueiredo Porto
Due to the limitations of Chagas disease therapy, microalgae can be promising in the search of new trypanocidal compounds, since these organisms produce bioactive compounds with large pharmaceutical applications, including antiparasitic effects. In this work, trypanocidal activity of aqueous extract of Tetradesmus obliquus and, for the first time, aqueous extract of Chlorella vulgaris, were evaluated against trypomastigote forms of Trypanosoma cruzi. In addition, cytotoxic activity in Vero cells was evaluated. Our results showed that C. vulgaris and T. obliquus present trypanocidal activity (IC50 = 32.9 µg ml−1 and 36.4 µg ml−1, respectively), however, C. vulgaris did not present cytotoxic effects in Vero cells (CC50 > 600 µg ml−1) and displayed a higher selectivity against trypomastigotes forms of T. cruzi (SI > 18). Thus, microalgae extracts, such as aqueous extract of C. vulgaris, are promising potential candidates for the development of natural antichagasic drugs. Graphical Abstract

22 February 2024 in Parasite Immunology
Verified
Journal Article
Closed access
DTDiego José Lira Torres
Diego José Lira Torres
KOKamila Kássia dos Santos Oliveira
Kamila Kássia dos Santos Oliveira
MBMichelle da Silva Barros
Michelle da Silva Barros
LMLeyllane Rafael Moreira
Leyllane Rafael Moreira
LFLuciane de Freitas Firmino
Luciane de Freitas Firmino
VLVirginia Maria Barros de Lorena
Virginia Maria Barros de Lorena

13 September 2024 in Immunity, Inflammation and Disease
Verified
Journal Article
Open access
KOKamila Kássia dos Santos Oliveira
Kamila Kássia dos Santos Oliveira
DTDiego José Lira Torres
Diego José Lira Torres
MBMichelle da Silva Barros
Michelle da Silva Barros
LMLeyllane Rafael Moreira
Leyllane Rafael Moreira
CJClaudeir Dias da Silva Junior
Claudeir Dias da Silva Junior
VLVirginia Maria Barros de Lorena
Virginia Maria Barros de Lorena
Introduction: Chagas disease is caused by the protozoan Trypanosoma cruzi and is clinically divided into acute and chronic phases. Chronic Chagas cardiomyopathy is the most studied manifestation of the disease. Vitamin D deficiency has been suggested as a risk factor for cardiovascular disease. No studies demonstrate the action of this hormone in the cells of patients with chronic Chagas heart disease.Objective: To evaluate the in vitro immunomodulatory effect of vitamin D on peripheral blood mononuclear cells of patients with the different chronic clinical forms of Chagas disease. Evaluating vitamin D's in vitro effect on blood cells by producing cytokines.Methods: Thirteen patients of the undetermined form (IND), 13 of the mild cardiac form (CARD1) and 14 of the severe cardiac form (CARD2) of Chagas disease, and 12 with idiopathic heart disease (CARDid) were included. The cells obtained from peripheral blood were treated in vitro with vitamin D (1 × 10−7 M) for 24 h and cytokines were dosed in the culture supernatant.Results: Although it was not possible to demonstrate statistically significant differences between the groups studied, our data showed that the cells treated with vitamin D modify (p < .05) the production of interferon‐γ (IFN‐γ) (decrease in IND), tumor necrosis factor‐α (TNF‐α) (decreased in CARD1 and CARDid), interleukin (IL)‐6 (increased in all groups), and IL‐10 (decreased in CARD1, CARD2, and CARDid) when compared to untreated cells.Conclusion: In vitro treatment with vitamin D distinctly modulated the production of cytokines by mononuclear cells of peripheral blood among patients with chronic and indeterminate cardiac clinical forms of Chagas disease.